Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?

Overview of attention for article published in Cancer Management and Research, March 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 101 Dimensions

Readers on

mendeley: 81 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 3,689 followers.

RT @62Shamsi: Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy. Bibi Kul…

04 Mar 2018

Reply Repost Favourite

RT @62Shamsi: Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy. Bibi Kul…

04 Mar 2018

Reply Repost Favourite

Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy. Bibi Kulsoom et al. https://t.co/sQAwvM2DJO

04 Mar 2018

Reply Repost Favourite

Dove Medical Press

Article Metrics

Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?

About this Attention Score

Mentioned by

Citations

Readers on